SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Philip Morris - A Stock For Wealth Or Poverty (MO)
MO 58.52+0.8%2:48 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: md1derful who wrote (6147)3/13/2001 8:40:19 PM
From: Xianming Liu  Read Replies (1) of 6439
 
Doc:

Last year tech and drug stocks shown very significant negative correlation. Drug stocks would generally move up when tech stocks dropped and vis versa. What probably happened was growth fund managers were switching between drug and tech sectors in response to market news. However, I have noticed that both drug and tech sector are down significantly in this year. I am wondering where the cash raised by the growth funds has gone. Before tech stocks became growth stocks 10 years ago, companies such as MRK and MO were considered high quality growth stocks. 10 years ago, big MO accounted for 2%-3% of market cap of S&P 500. Today, it is around 1%. If we just simply return to good old days, MO would move up significantly (assuming, of course, that S&P 500 does not drop sharply from here). For this to happen, growth funds have to court MO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext